Search

Your search keyword '"Mirani, Marco"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Mirani, Marco" Remove constraint Author: "Mirani, Marco"
32 results on '"Mirani, Marco"'

Search Results

5. SGLT2-inhibitors are effective and safe in the elderly: The SOLD study

8. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

13. Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)

15. AWARE. A web application to rapidly assess cardiovascular risk in Type 2 Diabetes Mellitus.

17. SGLT2-Inhibitors are Effective and Safe in the Elderly: The SOLD Study

18. 112 Safety and biochemical efficacy of sodium–glucose cotransporter 2 inhibitors based on cardiovascular risk profile and volume status in a real-world diabetic population

20. Outcome of SARS-COV-2-Related Thyrotoxicosis in Survivors of COVID-19: A Prospective Study

22. Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy

24. Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

25. Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study.

26. Reply to letter to the editor by Bonaventura et al.

32. 367-P: Cardiovascular Risk Categories in Patients with Diabetes According to 2019 ESC/EASD Guidelines in Clinical Practice: Use of a Dedicated App (AWARE).

Catalog

Books, media, physical & digital resources